CHF1.00
6.54%
SIX Swiss Exchange, Oct 05, 05:30 pm CEST. Closed.
ISIN
IL0010855885
Symbol
SHLTN

SHL Telemedicine Stock price

CHF1.00
-0.07 6.10% 1M
-0.07 6.10% 6M
-0.18 15.25% YTD
-0.04 3.85% 1Y
-9.20 90.20% 3Y
-15.50 93.94% 5Y
-5.88 85.47% 10Y
-3.91 79.63% 20Y
SIX Swiss Exchange, Closing price Mon, Oct 05 2026
-0.07 6.54%
ISIN
IL0010855885
Symbol
SHLTN

Is SHL Telemedicine a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,120 stocks worldwide.

Key metrics

Basic
Market capitalization
CHF39.7m
Enterprise Value
CHF32.5m
Net debt
positive
Cash
CHF16.0m
Shares outstanding
37.1m
Valuation
P/E
negative
P/S | estimate
0.8 | -
EV/Sales | estimate
0.6 | -
EV/FCF | ex SBC
negative | negative
P/B
1.1
Dividends
DPS
CHF0.00
Yield 1Y | 5Y
0.0% | 0.0%
Growth 1Y | 5Y
- | -
Payout 1Y | 3Y
0.0% | 0.0%
Increased
0 Years
Financials
Revenue | estimate
CHF51.5m | -
EBITDA
CHF-4.5m
EBIT
CHF-10.5m
Net Income
CHF-12.4m
Free Cash Flow | ex SBC
CHF-2.9m | CHF-3.2m
Growth
Revenue | estimate
9.3% | -
EBITDA
71.7%
EBIT
52.0%
Net Income
47.4%
Free Cash Flow
25.1%
Margin
Gross
45.9%
EBITDA
-8.8%
EBIT
-20.4%
Net
-24.1%
Free Cash Flow | ex SBC
-5.6% | -6.1%
Financial Health
Equity Ratio
51.7%
Return on Equity
-35.1%
ROCE
-23.1%
ROIC
-36.2%
Debt/Equity
0.2
Share-Based Compensation & Dilution
SBC | % of Revenue
CHF260.0k | 0.5%
SBC as % of FCF
-
SBC Growth 1Y
52.9%
Share Count Growth 1Y
24.4%
Shareholder Yield
-24.4%
More
EPS
CHF-0.3
FCF per Share
CHF-0.1
Short interest
-
Employees
526
Rev per Employee
CHF90.0k

SHL Telemedicine Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a SHL Telemedicine forecast:

3x Hold
43%
4x Sell
57%

Analyst Opinions

7 Analysts have issued a SHL Telemedicine forecast:

Hold
43%
Sell
57%

Financial data from SHL Telemedicine

Jun '26
+/-
%
51 51
9% 9%
100%
- Direct Costs 28 28
8% 8%
54%
24 24
11% 11%
46%
- Selling and Administrative Expenses 23 23
4% 4%
45%
- Research and Development Expense 3.34 3.34
21% 21%
6%
-4.51 -4.51
72% 72%
-9%
- Depreciation and Amortization 5.96 5.96
1% 1%
12%
EBIT (Operating Income) EBIT -10 -10
52% 52%
-20%
Net Profit -12 -12
47% 47%
-24%

In millions CHF.

Don't miss a Thing! We will send you all news about SHL Telemedicine directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

SHL Telemedicine Ltd. engages in the development and market of advanced personal telemedicine solutions, which focuses on cardiovascular and related diseases. Its products and solutions include congestive heart failure, chronic obstructive pulmonary disease and cardiac monitoring services. The company was founded by Yoram Alroy and Elon Shalev in 1987 and is headquartered in Tel Aviv, Israel.

Head office Israel
CEO Mr. Arnon
Employees 526
Founded 1987
Website www.shl-telemedicine.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today